Disc Medicine, Inc. (IRON)
68.42
-0.07
(-0.10%)
USD |
NASDAQ |
Sep 22, 16:00
68.42
0.00 (0.00%)
After-Hours: 19:23
Disc Medicine Price to Book Value : 4.073 for Sept. 22, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 21, 2026 | 4.077 |
| September 18, 2026 | 4.139 |
| September 17, 2026 | 4.118 |
| September 16, 2026 | 4.082 |
| September 15, 2026 | 4.006 |
| September 14, 2026 | 4.103 |
| September 11, 2026 | 4.170 |
| September 10, 2026 | 4.413 |
| September 09, 2026 | 4.554 |
| September 08, 2026 | 4.574 |
| September 04, 2026 | 4.716 |
| September 03, 2026 | 4.725 |
| September 02, 2026 | 4.765 |
| September 01, 2026 | 4.683 |
| August 31, 2026 | 4.682 |
| August 28, 2026 | 4.764 |
| August 27, 2026 | 4.914 |
| August 26, 2026 | 4.921 |
| August 25, 2026 | 4.906 |
| August 24, 2026 | 4.818 |
| August 21, 2026 | 4.751 |
| August 20, 2026 | 4.693 |
| August 19, 2026 | 4.781 |
| August 18, 2026 | 4.774 |
| August 17, 2026 | 4.765 |
| Date | Value |
|---|---|
| August 14, 2026 | 4.693 |
| August 13, 2026 | 4.763 |
| August 12, 2026 | 4.797 |
| August 11, 2026 | 4.834 |
| August 10, 2026 | 4.660 |
| August 07, 2026 | 4.610 |
| August 06, 2026 | 4.610 |
| August 05, 2026 | 4.697 |
| August 04, 2026 | 4.631 |
| August 03, 2026 | 4.543 |
| July 31, 2026 | 4.584 |
| July 30, 2026 | 4.715 |
| July 29, 2026 | 4.385 |
| July 28, 2026 | 4.444 |
| July 27, 2026 | 4.441 |
| July 24, 2026 | 4.412 |
| July 23, 2026 | 4.516 |
| July 22, 2026 | 4.424 |
| July 21, 2026 | 4.499 |
| July 20, 2026 | 4.428 |
| July 17, 2026 | 4.533 |
| July 16, 2026 | 4.374 |
| July 15, 2026 | 4.525 |
| July 14, 2026 | 4.465 |
| July 13, 2026 | 4.523 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Recursion Pharmaceuticals, Inc. | 2.367 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.97 |
| Anika Therapeutics, Inc. | 2.033 |
| BioCryst Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| PEG Ratio | -0.2213 |
| Price | 68.42 |
| Earnings Yield | -9.61% |
| Market Cap | 2.624B |
| PEGY Ratio | -0.2213 |